Gene · 7941
Papers4,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2022 | 36329806 | PubTator, text mining | PubMed |
| TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. | Sci Rep | 2022 | 36329152 | PubTator, text mining | PubMed |
| A retrospective study of immunoglobulin E as a biomarker for the diagnosis of acute ischemic stroke with carotid atherosclerotic plaques. | PeerJ | 2022 | 36317119 | PubTator, text mining | PubMed |
| Membrane Association Allosterically Regulates Phospholipase A2 Enzymes and Their Specificity. | Acc Chem Res | 2022 | 36315840 | PubTator, text mining | PubMed |
| Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A2 in Ischemic Stroke. | Cardiovasc Ther | 2022 | 36313479 | PubTator, text mining | PubMed |
| GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer. | PeerJ | 2022 | 36312753 | PubTator, text mining | PubMed |
| Aptamer-based applications for cardiovascular disease. | Front Bioeng Biotechnol | 2022 | 36312558 | PubTator, text mining | PubMed |
| Development and validation of a clinical predictive model for 1-year prognosis in coronary heart disease patients combine with acute heart failure. | Front Cardiovasc Med | 2022 | 36312262 | PubTator, text mining | PubMed |
| Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease. | Curr Top Med Chem | 2022 | 36305124 | PubTator, text mining | PubMed |
| Obesity and Coronary Artery Disease: An Updated Systematic Review 2022. | Cureus | 2022 | 36299943 | PubTator, text mining | PubMed |
| Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. | Pharmaceuticals (Basel) | 2022 | 36297390 | PubTator, text mining | PubMed |
| Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients. | Nutrients | 2022 | 36297097 | PubTator, text mining | PubMed |
| Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. | J Clin Med | 2022 | 36294361 | PubTator, text mining | PubMed |
| Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation. | Int J Mol Sci | 2022 | 36293289 | PubTator, text mining | PubMed |
| Genetic Association Study and Machine Learning to Investigate Differences in Platelet Reactivity in Patients with Acute Ischemic Stroke Treated with Aspirin. | Biomedicines | 2022 | 36289824 | PubTator, text mining | PubMed |
| Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses. | Immun Ageing | 2022 | 36289515 | PubTator, text mining | PubMed |
| The effect of a low dose hydrogen-oxygen mixture inhalation in midlife/older adults with hypertension: A randomized, placebo-controlled trial. | Front Pharmacol | 2022 | 36278221 | PubTator, text mining | PubMed |
| Temporal associations between leukocytes DNA methylation and blood lipids: a longitudinal study. | Clin Epigenetics | 2022 | 36274151 | PubTator, text mining | PubMed |
| A novel variant in TLE6 is associated with embryonic developmental arrest (EDA) in familial female infertility. | Sci Rep | 2022 | 36271123 | PubTator, text mining | PubMed |
| Emerging biomarkers for the detection of cardiovascular diseases. | Egypt Heart J | 2022 | 36264449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7941/papers?page=33